TITLE

Plans, PBMs promote generics to reel in Rx spending

AUTHOR(S)
Gunsauley, Craig
PUB. DATE
January 2003
SOURCE
Employee Benefit News;Jan2003, Vol. 17 Issue 1, p27
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the promotion of generic drugs by U.S. pharmacy benefit managers (PBM) in an effort to decrease spending on prescription drugs as of January 1, 2003. Measures done by PBM to promote generic drug; Reason for the inability of generic drug manufacturers to engage in sampling; Market share of generic medications in 2001.
ACCESSION #
8904414

 

Related Articles

  • Generics. Scheller, Melanie // Current Health 2;Dec96, Vol. 23 Issue 4, p30 

    Provides information on generic drugs. Differentiation of generic drugs from brand name drugs; Pricing difference between generics and brand name drugs; Drug effectiveness.

  • Generic drugs, and the consumer. Goldberg, Gene L. // Executive Health's Good Health Report;Jan1995, Vol. 31 Issue 4, p4 

    Focuses on generic drugs. Comparison of generic and brandname drugs; Advantages in using generics; Definition of generic drugs; Approval of the Food and Drug Administration.

  • Generic usage depends on type of doctor, class of drug. Snyder, Karyn // Drug Topics;11/20/95 Generics, Vol. 139 Issue 22, p2 

    Analyzes trends in the generic drug industry. Availability of more generic drugs; Gain of acceptance from doctors; Substitution of generic drugs for brands.

  • How safe are foreign-made generic drugs? Helwick, Caroline // Drug Topics;11/20/95 Generics, Vol. 139 Issue 22, p22S 

    Discusses the safety of imported generic drugs. Difficulty of regulating imported drugs; Major suppliers; Use of standard system.

  • Generic, brand firms battle across Atlantic on patents. Conlan, Michael F. // Drug Topics;11/3/97, Vol. 141 Issue 21, p95 

    Presents information on the generic drug industry, while focusing on the battle between generic firms across the Atlantic over pharmaceutical patents. Details on the status of the generic industry in the United States; Information on the Generic Pharmaceutical Industry Association.

  • Washington update. Wechsler, Jill // Formulary;May98, Vol. 33 Issue 5, p480 

    Focuses on the debate on the therapeutic equivalence of generic versions of narrow therapeutic index medications in the United States. Poor understanding of Food and Drug Administration policies and procedures; Use of individual bioequivalency standard to measure both innovator and generic drug...

  • Antidote. Siegel, Marc // Medical Marketing & Media;May2011, Vol. 46 Issue 5, p10 

    The article addresses the increase in the utilization of generic drugs in the U.S.

  • GENERIC DRUG FACTS.  // Monthly Prescribing Reference;Dec2011, Vol. 27 Issue 12, pA-24 

    The article offers information on the abbreviated new drug application, also known as generic drugs, in the U.S.

  • Drug deals.  // Redbook;Sep94, Vol. 183 Issue 5, p40 

    Reports that generic drugs are manufactured by the same manufacturers of expensive drugs. Federal standards required for generic drugs.

  • Generic health measurement: Past accomplishments and a measurement paradigm for the 21st century. McHorney, Colleen A. // Annals of Internal Medicine;10/15/97 Part 2 of 2, Vol. 127 Issue 8, p743 

    Generic health surveys have been proposed for use in increasingly diverse applications and populations. This paper describes the history of generic tools in the past 30 years and suggests a more modern measurement platform for advances in the 21st century. Many generic tools lack the precision...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics